Certified by Founder Lodge
Asher Biotherapeutics
United States - South San Francisco , California
START UP
1 Disclosed Funding Rounds $55,000,000
0 Participating Investments
-
Founded date
2019
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Asher Bio is a biotechnology company developing precisely targeted immunotherapies for cancer and other diseases. Our cis-targeting platform aims to enable selective activation of specific im
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| April, 17 ,2024 | Series C | $55,000,000 |
Wellington Management
Janus Henderson Investors
Third Rock Ventures
Bristol Myers Squibb
Boxer Capital, LLC
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Govstream.ai | $3,600,000 | (Dec 5, 2025)
ZincFive, Inc. | $30,000,000 | (Dec 5, 2025)
imper.ai | $28,000,000 | (Dec 5, 2025)
SPhotonix Inc | $4,500,000 | (Dec 5, 2025)
Multifactor (YC F25) | $15,000,000 | (Dec 5, 2025)
